Literature DB >> 11940222

Primary osteosarcoma of the uterine corpus: case report and review of the literature.

Mu Su1, Takuo Tokairin, Yuji Nishikawa, Tomomi Yoshioka, Osamu Takahashi, Hitoshi Watanabe, Yuko Doi, Yasufumi Omori, Toshiaki Yoshioka, Masato Sageshima, Toshinobu Tanaka, Katsuhiko Enomoto.   

Abstract

A rare case of rapidly growing osteosarcoma that developed in the uterine corpus of a 62-year-old woman is presented. The tumor occupied almost the entire pelvic cavity and extended into the abdominal cavity, with marked involvement of the intestines. Histopathologically, the tumor was composed of an osteoblastic component, accompanied by conspicuous bone formation, and a fibroblastic component. The tumor cells were positive for vimentin and osteocalcin, as well as desmin, alpha-smooth muscle actin and muscle-specific actin, but negative for h-caldesmon. The results indicated myofibroblastic differentiation in a part of the tumor. A review of 14 reported cases and our case of uterine osteosarcoma revealed that this tumor has a biologically aggressive nature, although its histopathological and immunohistochemical features are similar to those of osteosarcomas in soft tissue and bone. As the prognosis of patients with this tumor is poor, it is of importance to differentiate this tumor from other types of tumors arising from the uterine corpus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11940222     DOI: 10.1046/j.1440-1827.2002.01325.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  2 in total

1.  Primary osteosarcoma of the uterus with cardiac and pulmonary metastases.

Authors:  Cynthia Abraham; Roisin O'Cearbhaill; Robert Soslow
Journal:  Gynecol Oncol Rep       Date:  2014-10-01

Review 2.  An unusual case of an osteosarcoma arising in a leiomyoma of the uterus.

Authors:  Mehmet Kefeli; Sancar Baris; Oguz Aydin; Levent Yıldız; Seda Yamak; Bedri Kandemir
Journal:  Ann Saudi Med       Date:  2012 Sep-Oct       Impact factor: 1.526

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.